Cite
MLA Citation
R Tzadok et al.. “P442 Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients.” Journal of Crohn's and colitis, vol. 15, n.d., pp. S441–S442. http://access.bl.uk/ark:/81055/vdc_100130764988.0x000010